Alzheimer’s player Anavex reveals SEC probe; shares dive

John Carroll Shares of Anavex took a nasty hit after the New York-based biotech issued a 10-K this morning that included news of an SEC probe, evidently focused on "unusual" ...

Cadient Group reveals new release of insights and analytics platform

mia.burns By Mia Burns Cadient Group has unveiled the next generation of its insights and analytics solution Reveal. The solution is a proprietary SaaS business intelligence solution ...

Teva reveals CEO pay secret: Levin collected $4.1M in 2012

Tracy Staton According to those court documents, Levin's base salary was 5.4 million shekels, with a bonus of 4.3 million shekels, or $ 1.51 million and $ 1.2 million, respectively. ...

Healthcare Businesswomen’s Association Boston Chapter’s 2013 Forum Reveals 4 Ways to Create Value in Healthcare Reform

barbara.lempert July 9, 2013, Boston, MA – Key women healthcare leaders driving healthcare reform and innovation in Boston all agree on what is required for reform success ...

Report Reveals the Potential Gap between Consumer Pricing Expectations and Affordability

mia.burns New Health Care Market Report Reveals the Potential Gap between Consumer Pricing Expectations and Affordability YARDLEY, PA – June 20, 2013 – The Agency Inside® Harte-Hanks ...

GlaxoSmithKline reveals mixed results for diabetes contender in ‘crowded area’

Ryan McBride As has often been the case with GlaxoSmithKline's GLP-1 candidate albiglutide, a late-stage study in diabetics taking the drug and metformin offered some upbeat and ...

National survey reveals public and physician misperceptions about opioid dependence

mia.burns By Mia Burns A new national survey has revealed that both U.S. adults and primary care physicians hold various misperceptions and stereotypes about opioid dependence that ...

Acumen Pharma reveals A round closing to fund Alzheimer’s drug research

Ryan McBride Driven to test another amyloid-beta mechanism in Alzheimer's, Acumen Pharmaceuticals has wrapped up the first closing of a planned $ 20 million Series A round from ...

Novartis changes CFOs, reveals cuts to work force and chairman pay

Alok Saboo While the U.S. government was announcing its kickbacks lawsuit against Novartis, the Swiss drugmaker was putting the finishing touches on a few press releases of its own. ...

Alkermes reveals PhII success with antidepressant in blockbuster CNS plan

Ryan McBride Alkermes ($ ALKS) has a shot at offering a new option for treating depression in patients who don't respond to existing drugs. The company revealed positive preliminary ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS